DK128536B - 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof. - Google Patents

5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Info

Publication number
DK128536B
DK128536B DK556771AA DK556771A DK128536B DK 128536 B DK128536 B DK 128536B DK 556771A A DK556771A A DK 556771AA DK 556771 A DK556771 A DK 556771A DK 128536 B DK128536 B DK 128536B
Authority
DK
Denmark
Prior art keywords
naphthalenone
propoxy
dihydro
butylamino
tert
Prior art date
Application number
DK556771AA
Other languages
Danish (da)
Inventor
J Shavel
S Farber
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK128536B publication Critical patent/DK128536B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/38—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epoxy Compounds (AREA)
DK556771AA 1968-09-23 1971-11-12 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof. DK128536B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76185768A 1968-09-23 1968-09-23

Publications (1)

Publication Number Publication Date
DK128536B true DK128536B (en) 1974-05-20

Family

ID=25063434

Family Applications (2)

Application Number Title Priority Date Filing Date
DK503669AA DK125588B (en) 1968-09-23 1969-09-22 Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.
DK556771AA DK128536B (en) 1968-09-23 1971-11-12 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK503669AA DK125588B (en) 1968-09-23 1969-09-22 Analogous process for the preparation of 5- [3-tert-butylamino) -2-hydroxypropoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.

Country Status (15)

Country Link
US (1) US3641152A (en)
JP (1) JPS4843734B1 (en)
BE (1) BE739195A (en)
CH (1) CH525183A (en)
DE (2) DE1948144C3 (en)
DK (2) DK125588B (en)
ES (1) ES371737A1 (en)
FI (1) FI51936C (en)
FR (1) FR2018626B1 (en)
GB (1) GB1223527A (en)
IT (1) IT1033032B (en)
NL (1) NL139166B (en)
NO (1) NO128869B (en)
SE (1) SE362414B (en)
ZA (1) ZA695648B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755071A (en) * 1969-09-17 1971-02-22 Warner Lambert Pharmaceutical METHOD FOR RESOLVING DL-5- / 3- (TERBUTYLAMINO) -2- HYDROXY-PROPOXY / -3,4-DIHYDRO-1 (2H) NAPHTHALENONE
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
DE2130393C3 (en) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanols and their salts with acids and their use in combating heart disease
FR2119843B1 (en) * 1970-12-28 1974-03-22 Laroche Navarro Labo
JPS5122737Y2 (en) * 1972-12-30 1976-06-11
US3966749A (en) * 1975-02-10 1976-06-29 Interx Research Corporation Novel synthesis of optically active m-acyloxy-α-[(methylamino)methyl]benzyl alcohols, the pharmaceutically acceptable acid addition salts thereof and intermediate useful in the preparation thereof
GB1493848A (en) * 1975-07-24 1977-11-30 Beecham Group Ltd Aryltetralins
CH621330A5 (en) * 1976-05-14 1981-01-30 Sandoz Ag
DE2810869A1 (en) * 1977-03-24 1978-09-28 Sandoz Ag 3-AMINO-2-HYDROXYPROPOXY DERIVATIVES, THEIR PRODUCTION AND USE
US4176183A (en) * 1977-05-02 1979-11-27 Merck & Co., Inc. Novel naphthyridines
US4270005A (en) * 1977-11-14 1981-05-26 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
CH641147A5 (en) * 1979-01-17 1984-02-15 Sandoz Ag 3-AMINO-2-HYDROXYPROPOXYARYL DERIVATIVE, ITS PREPARATION AND REMEDIES CONTAINING THEREOF.
DE2943406A1 (en) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
FR2507181A1 (en) * 1981-06-05 1982-12-10 Sanofi Sa NOVEL ETHERS OF PHENOL ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESS FOR PREPARING THEM AND USE THEREOF IN MEDICAMENTS
SE8801518D0 (en) * 1988-04-22 1988-04-22 Astra Pharma Prod A NOVEL PROCESS
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
ES2065278B1 (en) * 1993-06-24 1995-09-01 Medichem Sa LEVOBUNOLOL ENANTIOSELECTIVE PROCEDURE FOR OBTAINING.
ES2265437T3 (en) * 2000-07-27 2007-02-16 Pharmacia Corporation EPOXI-STEROID ANTAGONIST COMBINATION THERAPY OF ALDOSTERONE AND BETA-ADRENERGIC ANTAGONIST FOR TREATMENT OF CONGESTIVE CARDIAC INSUFFICIENCY.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1023214A (en) * 1962-12-17 1966-03-23 Ici Ltd Carbocyclic hydroxyamines

Also Published As

Publication number Publication date
DE1948144B2 (en) 1979-05-03
NO128869B (en) 1974-01-21
BE739195A (en) 1970-03-23
US3641152A (en) 1972-02-08
FI51936C (en) 1977-05-10
JPS4843734B1 (en) 1973-12-20
DE1967162C3 (en) 1981-03-19
FR2018626A1 (en) 1970-06-26
DE1948144A1 (en) 1970-03-26
DE1948144C3 (en) 1980-01-17
IT1033032B (en) 1979-07-10
GB1223527A (en) 1971-02-24
CH525183A (en) 1972-07-15
NL6914077A (en) 1970-03-25
DE1967162B1 (en) 1980-07-31
FR2018626B1 (en) 1973-06-08
NL139166B (en) 1973-06-15
ES371737A1 (en) 1972-03-16
SE362414B (en) 1973-12-10
ZA695648B (en) 1971-03-31
FI51936B (en) 1977-01-31
DK125588B (en) 1973-03-12

Similar Documents

Publication Publication Date Title
DK128536B (en) 5- (2,3-Epoxy-propoxy) -3,4-dihydro-1 (2H) -naphthalenone for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3 , 4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.
DK113854B (en) Process for the preparation of aminoacytylenes, or acid addition salts thereof.
DK104936C (en) Process for the preparation of 2α-cyano-3-oxo-4,4-dialkyl-Δ <5> -androstenes or salts thereof.
DK114903B (en) Process for the preparation of 9,10-dihydro-ergovaline or acid addition salts thereof.
DK126113B (en) Ethers of Δ <1,3,5 (10)> - ostratrien-3-ol or 3-ethers or 3-esters thereof for use as contraceptives.
DK122960B (en) Quinazoline derivatives for use as intermediates in the preparation of 1,4-benzodiazepine-4-oxides.
DK129649B (en) Tetralone ether-containing material for use as an intermediate in the preparation of 5- [3- (tert-butylamino) -2-hydroxy-propoxy] -3,4-dihydro-1 (2H) -naphthalenone or acid addition salts thereof.
DK135577B (en) Substituted omega-amino-acetophenone for use as an intermediate in the preparation of 3,5-disubstituted phenylethanolamine compounds or acid addition salts thereof.
DK119705B (en) Process for the preparation of 4,5-disubstituted 2-alkyl-3-hydroxy-pyridines or acid addition salts thereof.
DK96694C (en) Process for the preparation of Δ <8 (9)> - 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- (3'-acyloxy-cyclopentano- (2 ', 1')) - octahydronaphthalene.
DK135803B (en) 3,3,6-trimethyl-4-arylsulfonyl-5-heptene-1-acid derivatives for use as intermediates in the preparation of trans-chrysanthemic acid derivatives.
DK122073B (en) Analogous process for the preparation of 5- [3- (N-methylamino) propyl] -5H-dibenzo- [a, d] -cycloheptenes or acid addition salts thereof.
DK94353C (en) Process for the preparation of 4,4 ', 4 "trihalogenetritanols or their aluminum or iron complex salts.
DK133875B (en) Analogous process for the preparation of 3- (2,2,2-trifluoroethylthiomethyl) -7-sulfamyl-3,4-dihydrobenzo-1,1-dioxo-1-thia-2,4-diazine compounds or salts thereof.
DK103397C (en) Process for the preparation of 4-substituted 1,2-diaryl-3,5-dioxo-pyrazolidines or salts thereof.
DK99021C (en) Process for the preparation of 4-substituted 1,2-diaryl-3,5-dioxo-pyrazolidines or salts thereof.
DK105030C (en) Process for the preparation of 2- [5 ', 6', 7 ', 8'-tetrahydronaphthyl- (1') -amino] -imidazoline or acid addition salts thereof.
DK108253C (en) Process for the preparation of 5- [3- (N-methylamino) -propyl] -5H-dibenzo- [a, d] -cycloheptene compounds or acid addition salts thereof.
DK97937C (en) Process for the preparation of Δ <8 (9)> - 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclopentano- (2 ', 1')] - octahydronaphthalenes.
DK94942C (en) Process for the preparation of Δ <8 (9)> - 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- (3'-acyloxy-cyclopentano- (2 ', 1')) - octahydronaphthalenes.
DK65338C (en) Process for the Preparation of Δ <4,5> -unsaturated 3-Keto Compounds of the Androstane Row.
DK91277C (en) Process for the preparation of 4-position bicyclically substituted 3,5-dioxo-pyrazolidines or salts thereof.
DK98759C (en) Process for the preparation of 1,2-diphenyl-4-carbamoyl-3,5-pyrazolidinedione or salts thereof.
DK99637C (en) Process for the preparation of 4-substituted 1-aryl-2-hydroxyphenyl-3,5-dioxo-pyrazolidines or salts thereof.
DK114827B (en) Process for the preparation of 5-keto-11-hydroxy-17β-acyloxy-Δ <9> -des-A-ester or 5,11-diketo-17β-acyloxy-Δ <9> -des-A-ester.

Legal Events

Date Code Title Description
PUP Patent expired